Have been absent from food allergy science
Ability to assess severity of allergic disease
2/3 of children are misdiagnosed due to imprecise tests
Surrogate biomarkers to determine therapeutic response
As many as 60% of food allergy sufferers may be
misdiagnosed, leading to unnecessary food avoidance, increased patient anxiety, and annual costs of nearly $25 billion in the US alone. AllerGenis is working to change that.
We leverage our deep expertise in immunology and
bioinformatics to bring next-generation solutions to the
diagnosis and management of food allergies.
At AllerGenis, we are dedicated to harnessing 21st century
technology, science and data to improve the lives of
millions of food allergy patients and their families.